Tirzepatide is a first-in-class medication that acts as a dual receptor agonist, mimicking two natural gut hormones:
GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide).
By activating both receptors, it provides more significant weight loss and blood sugar control than medications that target GLP-1 alone.
Tirzepatide is the peptide name for for the weight loss drug manufactured by Mounjaro.
For research use only, not to be used in clinical trials involving humans. Documentation is for information only.
Note:
With this option, we will mix it for you with bacteriostatic water and put it into a disposable pen (no vial received). The pen offers easy and accurate dosing for your research purposes, adjustable from 1 to 60 iu’s. It comes complete with enough alcohol swabs and needles to complete your research, all contained in a case.
If you already have a reusable pen you can also buy this peptide premixed in a cartridge only (see alternate product).